Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Volume 32 - Issue 9 - September, 2020

September 2020 Table of Contents
September 2020 Table of Contents
09/01/2020
TOC and Whole Issue PDF
TOC and Whole Issue PDF
TOC and Whole Issue PDF
09/01/2020
Journal of Invasive Cardiology
Transcatheter Aortic Valve Replacement Without the Use of Contrast Medium: An Alternative Safe Implantation Technique
Transcatheter Aortic Valve Replacement Without the Use of Contrast Medium: An Alternative Safe Implantation Technique
09/01/2020

Tamer Owais, MD1,2*; Mohammad El Garhy, MD1,3,4*; Jürgen Fuchs, MD5; Mathias Schreiber, MD1; Evaldas Girdauskas, MD6; Thomas Kuntze, MD1

Tamer Owais, MD1,2*; Mohammad El Garh...
New transcatheter equipment and accumulated experience have stimulated further refinements in implantation techniques. We aimed to compare the outcomes of transfemoral transcatheter aortic valve replacement with and without the use of...
New transcatheter equipment and accumulated experience have stimulated further refinements in implantation techniques. We aimed to compare the outcomes of transfemoral transcatheter aortic valve replacement with and without the use of...
New transcatheter equipment and...
09/01/2020
Journal of Invasive Cardiology
Use of MitraClip to Target Obstructive SAM in Severe Diffuse-Type Hypertrophic Cardiomyopathy: Case Report and Review of Literature
Use of MitraClip to Target Obstructive SAM in Severe Diffuse-Type Hypertrophic Cardiomyopathy: Case Report and Review of Literature
09/01/2020

Ashleigh Long, MD, PhD and Paul Mahoney, MD

Ashleigh Long, MD, PhD and Paul Mahon...
Hypertrophic cardiomyopathy (HCM) is frequently associated with abnormalities of the mitral valve; these commonly include systolic anterior motion of anterior mitral leaflets that contribute to dynamic left ventricular outflow tract...
Hypertrophic cardiomyopathy (HCM) is frequently associated with abnormalities of the mitral valve; these commonly include systolic anterior motion of anterior mitral leaflets that contribute to dynamic left ventricular outflow tract...
Hypertrophic cardiomyopathy...
09/01/2020
Journal of Invasive Cardiology
Right Heart Catheterization: Right From the Anatomical Snuffbox
Right Heart Catheterization: Right From the Anatomical Snuffbox
09/01/2020

Hady Lichaa, MD

Hady Lichaa, MD
We present two cases where a right heart catheterization was performed from the anatomical snuffbox through the distal cephalic vein along with a left heart catheterization from the distal radial artery.
We present two cases where a right heart catheterization was performed from the anatomical snuffbox through the distal cephalic vein along with a left heart catheterization from the distal radial artery.
We present two cases where a...
09/01/2020
Journal of Invasive Cardiology

Feature

Outcomes of Percutaneous Coronary Intervention in Cardiac Transplant Patients: A Binational Analysis Derived From the United Kingdom and United States
Original Contribution
Outcomes of Percutaneous Coronary Intervention in Cardiac Transplant Patients: A Binational Analysis Derived From the United Kingdom and United States
09/01/2020

Vinayak Nagaraja, MBBS, MS, MMed (Clin Epi), FRACP*1; Muhammad Rashid, PhD*1; David L. Fischmann, MD2; H. Vernon Anderson, MD3; Tim Kinnaird, MD4; Peter Ludman, MD5; Samir R. Kapadia, MD6; Randall C. Starling, MD6; Chadi Alraies, MD7; Chun Shing Kwok, MBBS, PhD, MSc, BSc, MRCP(UK) 1; Mohamed O. Mohamed, MBChB1; Nick Curzen, PhD8; Mamas A. Mamas, DPhil1

Vinayak Nagaraja, MBBS, MS, MMed (Cli...
This study aims to compare and contrast the indications, clinical and procedural characteristics, and periprocedural outcomes of patients with cardiac transplant undergoing percutaneous coronary intervention in the United States and United...
This study aims to compare and contrast the indications, clinical and procedural characteristics, and periprocedural outcomes of patients with cardiac transplant undergoing percutaneous coronary intervention in the United States and United...
This study aims to compare and...
09/01/2020
Journal of Invasive Cardiology
Effect of Preloading With High Dose of Rosuvastatin on Serum Levels of Inflammatory Markers After Percutaneous Coronary Intervention
Original Contribution
Effect of Preloading With High Dose of Rosuvastatin on Serum Levels of Inflammatory Markers After Percutaneous Coronary Intervention
09/01/2020

Juliano R. Slhessarenko, MD1; Mario Hirata, PhD1,2; Amanda Sousa, MD, PhD1; Gisele M. Bastos, PhD1; Elisa M.S. Higa, PhD3; Margareth G. Mouro, BS3; Guilherme C. Sobrera, MS2; Renata D. Slhessarenko, PhD4; Renata Viana, MD1; Alexandre Abizaid, MD, PhD1; J. Ribamar Costa Jr, MD, PhD1

Juliano R. Slhessarenko, MD1; Mario H...
We sought to assess the effects of a high loading dose of rosuvastatin (40 mg) on acute inflammatory response after coronary stenting. The primary goal was a comparison in the variation of the serum inflammatory markers and their gene...
We sought to assess the effects of a high loading dose of rosuvastatin (40 mg) on acute inflammatory response after coronary stenting. The primary goal was a comparison in the variation of the serum inflammatory markers and their gene...
We sought to assess the effects...
09/01/2020
Journal of Invasive Cardiology
A Sex-Based Analysis From the RAIN-CARDIOGROUP VII Study (VeRy Thin Stents for Patients With Left MAIn or BifurcatioN in Real Life) on Left Main Stenting
Original Contribution
A Sex-Based Analysis From the RAIN-CARDIOGROUP VII Study (VeRy Thin Stents for Patients With Left MAIn or BifurcatioN in Real Life) on Left Main Stenting
09/01/2020

Daniela Trabattoni, MD1; Sebastiano Gili, MD1; Giovanni Teruzzi, MD1; Pierluigi Omedè, MD2; Enrico Cerrato, MD3; Christian Templin, MD4; Davide Capodanno, MD5; Thomas Lüscher, MD4; Nicola Ryan, MD6; Giuseppe Venuti, MD5; Andrea Montabone, MD7; Wojciech Wojakowski, MD8; Andrea Rognoni, MD9; Gerard Helft, MD10; Diego Gallo, PhD11; Carlo Alberto Biolè, MD2; Radoslaw Parma, MD12; Leonardo De Luca, MD13; Filippo Figini, MD14; Satoru Mitomo, MD15; Alessio Mattesini, MD7; Giacomo Boccuzzi, MD16; Giorgio Quadri, MD3; Wojciech Wańha, MD8; Grzegorz Smolka, MD8; Zenon Huczek, MD12; Alaide Chieffo, MD15; Ivan Nuñez-Gil, MD6; Umberto Morbiducci, MD11; Mario Iannaccone, MD2; Carlo di Mario, MD7; Claudio Moretti, MD2; Maurizio D’Amico, MD2; Imad Sheiban, MD14; Javier Escaned, MD6; Fabrizio D’Ascenzo, MD2

Daniela Trabattoni, MD1; Sebastiano G...
There is a lack of data on clinical outcomes of percutaneous coronary intervention with ultrathin stents on unprotected left main coronary artery comparing women and men. In our study, all patients treated with unprotected left main...
There is a lack of data on clinical outcomes of percutaneous coronary intervention with ultrathin stents on unprotected left main coronary artery comparing women and men. In our study, all patients treated with unprotected left main...
There is a lack of data on...
09/01/2020
Journal of Invasive Cardiology
Predicting the Need For Permanent Pacing After Implantation of the Repositionable Lotus Transcatheter Aortic Valve
Original Contribution
Predicting the Need For Permanent Pacing After Implantation of the Repositionable Lotus Transcatheter Aortic Valve
09/01/2020

Roly Hilling-Smith, MD; Tiffany Kemp, MD; Maureen Dooley, MD; Rajiv Rampat, MD; Adam de Belder, MD; Andrew Hill, MD; James Cockburn, MD; Uday Trivedi, MD; David Hildick-Smith, MD; Michele Homsy, MD

Roly Hilling-Smith, MD; Tiffany Kemp,...
Permanent pacemaker implantation rates vary according to type of transcatheter aortic valve implantation (TAVI) device, implantation technique, and patient-related factors. We analyzed the baseline characteristics, and then the preprocedure...
Permanent pacemaker implantation rates vary according to type of transcatheter aortic valve implantation (TAVI) device, implantation technique, and patient-related factors. We analyzed the baseline characteristics, and then the preprocedure...
Permanent pacemaker implantation...
09/01/2020
Journal of Invasive Cardiology
Clinical Outcomes of Percutaneous Coronary Intervention for Chronic Total Occlusion in Native Coronary Arteries vs Saphenous Vein Grafts
Original Contribution
Clinical Outcomes of Percutaneous Coronary Intervention for Chronic Total Occlusion in Native Coronary Arteries vs Saphenous Vein Grafts
09/01/2020

Ahmad Shoaib, MD1; Thomas W. Johnson, MD2; Adrian Banning, MD3; Peter Ludman, MD4; Muhammad Rashid, PhD1; Jessica Potts, PhD1; Chun Shing Kwok, MBBS, PhD, MSc, BSc, MRCP(UK)1; Evan Kontopantelis, PhD5; Ziyad A. Azam, MBChB6; Tim Kinnaird, MD7; Mamas A. Mamas, DPhil1,5

Ahmad Shoaib, MD1; Thomas W. Johnson,...
There are limited data comparing outcomes of patients with previous coronary artery bypass grafting presenting with stable angina who undergo percutaneous coronary intervention to either a saphenous vein graft or a chronic total occlusion in...
There are limited data comparing outcomes of patients with previous coronary artery bypass grafting presenting with stable angina who undergo percutaneous coronary intervention to either a saphenous vein graft or a chronic total occlusion in...
There are limited data comparing...
09/01/2020
Journal of Invasive Cardiology
Evaluation of Effectiveness and Safety of Left Atrial Appendage Closure Under Moderate Conscious Sedation
Original Contribution
Evaluation of Effectiveness and Safety of Left Atrial Appendage Closure Under Moderate Conscious Sedation
09/01/2020

Ismail Ates, MD1; Konstantinos Marmagkiolis, MD2,3; Gulcan Kose, MD1; Cezar Iliescu, MD3; Mehmet Cilingiroglu, MD1,3

Ismail Ates, MD1; Konstantinos Marmag...
Left atrial appendage closure (LAAC) using the Watchman device has become a well-established therapeutic alternative to oral anticoagulation in high-risk patients for bleeding with paroxysmal, persistent atrial fibrillation (Afib) or...
Left atrial appendage closure (LAAC) using the Watchman device has become a well-established therapeutic alternative to oral anticoagulation in high-risk patients for bleeding with paroxysmal, persistent atrial fibrillation (Afib) or...
Left atrial appendage closure...
09/01/2020
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement

News

A study led by researchers from Shinshu University propose a simplified risk-scoring model helps clinicians assess when patients with cardiogenic shock can be safely weaned off from MCS devices, such as VA-ECMO or IMPELLA, using easily measurable health indicators like blood pressure and heart function. Credit Sho Suzuki from Shinshu University
Mechanical Circulatory Support
A Simple Risk Score for Weaning Patients From Mechanical Circulatory Support
10/23/2024
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu...
10/23/2024
Cath Lab Digest
The initial cases with the Luna TMVR System were conducted in Paraguay and the Republic of Georgia and supported by leading US structural heart experts and the Tioga Cardiovascular team.
Mitral Valve intervention
Tioga Cardiovascular Announces First-In-Human Cases With Its Luna Transcatheter Mitral Valve Replacement (TMVR) System
10/23/2024
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a...
10/23/2024
Cath Lab Digest
CABG
Black Patients More Likely to Die After Coronary Bypass Surgery
10/22/2024
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients,...
10/22/2024
Cath Lab Digest
Medaxiom survey
Cardiology Compensation and Production Reflect Post-Pandemic Changes to Provider Market
10/21/2024
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH,...
10/21/2024
Cath Lab Digest
Cardiology Innovations
Philips Showcases Next Level Cardiology Innovations for Improved Patient Care at TCT 2024
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of...
10/21/2024
Vascular Disease Management
Cardiovascular Risk After MI
Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
10/21/2024
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold...
10/21/2024
Vascular Disease Management
Pharmaceuticals
Acticor Biotech Repositions Glenzocimab in the Treatment of Myocardial Infarction
10/21/2024
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b,...
10/21/2024
Cath Lab Digest
PVD
Yale Study Finds Link Between Eczema and Peripheral Vascular Disease
10/21/2024
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred...
10/21/2024
Cath Lab Digest
plaque analysis
HeartFlow Announces New Category I CPT Code from the American Medical Association for AI-Enabled Plaque Analysis to Assess Risk for Coronary Artery Disease
10/18/2024
“We commend the AMA’s issuance of this upgraded Category I CPT billing code, which validates the technology’s clinical value in quantifying and characterizing plaque to help assess risk and personalize treatment for patients with coronary...
“We commend the AMA’s issuance of this upgraded Category I CPT billing code, which validates the technology’s clinical value in quantifying and characterizing plaque to help assess risk and personalize treatment for patients with coronary...
“We commend the AMA’s issuance...
10/18/2024
Cath Lab Digest
Hypertension
New Study Links Obesity to Elevated Hypertension Risk Among Young Middle Eastern Women
10/18/2024
“Young Middle Eastern women who are obese or overweight are facing a higher risk for the development of atherosclerotic cardiovascular disease and its associated risk factors like hypertension and Type Two diabetes,” said Mohammad Adnan Bani...
“Young Middle Eastern women who are obese or overweight are facing a higher risk for the development of atherosclerotic cardiovascular disease and its associated risk factors like hypertension and Type Two diabetes,” said Mohammad Adnan Bani...
“Young Middle Eastern women who...
10/18/2024
Cath Lab Digest

Advertisement

Advertisement

A study led by researchers from Shinshu University propose a simplified risk-scoring model helps clinicians assess when patients with cardiogenic shock can be safely weaned off from MCS devices, such as VA-ECMO or IMPELLA, using easily measurable health indicators like blood pressure and heart function. Credit Sho Suzuki from Shinshu University
Mechanical Circulatory Support
A Simple Risk Score for Weaning Patients From Mechanical Circulatory Support
10/23/2024
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu...
10/23/2024
Cath Lab Digest
Original Contribution
Intravascular Ultrasound in the Assessment of Coronary Artery Anomalies in Young Patients: A Tertiary Center Experience
10/23/2024
The authors describe a young population of patients with anomalous aortic origin of a coronary artery and myocardial bridge and review the safety of intravascular ultrasound in this population.
The authors describe a young population of patients with anomalous aortic origin of a coronary artery and myocardial bridge and review the safety of intravascular ultrasound in this population.
The authors describe a young...
10/23/2024
Journal of Invasive Cardiology
The initial cases with the Luna TMVR System were conducted in Paraguay and the Republic of Georgia and supported by leading US structural heart experts and the Tioga Cardiovascular team.
Mitral Valve intervention
Tioga Cardiovascular Announces First-In-Human Cases With Its Luna Transcatheter Mitral Valve Replacement (TMVR) System
10/23/2024
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a...
10/23/2024
Cath Lab Digest
Original Contribution
Comparison of Two Vascular Closure Device Strategies for Transfemoral Transcatheter Aortic Valve Replacement Using Suture-Based and Collagen-Plug-Based Techniques and Associated Vascular Complications
10/23/2024
The authors evaluated their experience with 2 distinct vascular closure device approaches using the Perclose ProGlide and the Angio-Seal, as well as the impact on vascular access site complications during transcatheter aortic valve...
The authors evaluated their experience with 2 distinct vascular closure device approaches using the Perclose ProGlide and the Angio-Seal, as well as the impact on vascular access site complications during transcatheter aortic valve...
The authors evaluated their...
10/23/2024
Journal of Invasive Cardiology
CABG
Black Patients More Likely to Die After Coronary Bypass Surgery
10/22/2024
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients,...
10/22/2024
Cath Lab Digest
Medaxiom survey
Cardiology Compensation and Production Reflect Post-Pandemic Changes to Provider Market
10/21/2024
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH,...
10/21/2024
Cath Lab Digest
Cardiology Innovations
Philips Showcases Next Level Cardiology Innovations for Improved Patient Care at TCT 2024
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of...
10/21/2024
Vascular Disease Management
Cardiovascular Risk After MI
Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
10/21/2024
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold...
10/21/2024
Vascular Disease Management
Pharmaceuticals
Acticor Biotech Repositions Glenzocimab in the Treatment of Myocardial Infarction
10/21/2024
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b,...
10/21/2024
Cath Lab Digest
PVD
Yale Study Finds Link Between Eczema and Peripheral Vascular Disease
10/21/2024
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred...
10/21/2024
Cath Lab Digest

September 2020 Volume 32 Issue 9

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement